C

Cancer Research Consortium of West Michigan | Grand Rapids, MI

Research site

(Unclaimed)

Location

100 Michigan St NE, MC012, Grand Rapids, Michigan, United States of America

Site insights

Top conditions

Top treatments

Trastuzumab

Dexamethasone

Prochlorperazine

Androgen

Ipilimumab

Talazoparib

Olanzapine

Orteronel

Vemurafenib

Atezolizumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 13 total trials

Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status

This is a phase II trial to examine the efficacy of neratinib plus trastuzumab or neratinib plus cetuximab in patients with "quadruple wild-type" (al...

Active, not recruiting

Metastatic Colorectal Cancer

Diagnostic Test: Guardant360 Diagnostic Test

Drug: Neratinib

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harb...

Enrolling

Multiple Myeloma

Advanced Solid Tumors

Drug: Trastuzumab and Pertuzumab

Drug: Palbociclib